(Q79719335)

English

[Interchangeability of biological drugs: considerations about the approval of biogeneric formulations in Chile]

scientific article published on 01 December 2006

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17277878

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17277878%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 December 2019

title

[Interchangeability of biological drugs: considerations about the approval of biogeneric formulations in Chile] (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17277878

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17277878%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

Iván Saavedra S

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17277878

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17277878%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 December 2019

Luis Quiñones S

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17277878

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17277878%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 December 2019

publication date

1 December 2006

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17277878

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17277878%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 December 2019

published in

Revista médica de Chile

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17277878

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17277878%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 December 2019

volume

134

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17277878

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17277878%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 December 2019

issue

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17277878

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17277878%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 December 2019

page(s)

1583-1588

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17277878

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17277878%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 December 2019

Identifiers

DOI

10.4067/S0034-98872006001200015

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17277878

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17277878%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 December 2019

PubMed publication ID

17277878

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17277878

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17277878%20AND%20SRC:MED&resulttype=core&format=json

(Q79719335)

[Interchangeability of biological drugs: considerations about the approval of biogeneric formulations in Chile]

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)